Split History
ETFs Holding SLNO »    SLNO Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Soleno Therapeutics is focused on the development and commercialization of therapeutics for the treatment of rare diseases. Co.'s primary candidate, Diazoxide Choline Controlled Release (DCCR) tablets, a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is being evaluated in a Phase III clinical development program. Co.'s research and development efforts are primarily focused on developing its primary candidate, DCCR tablets for the treatment of PWS, through late-stage clinical development. According to our SLNO split history records, Soleno Therapeutics has had 1 split.
SLNO split history picture
Soleno Therapeutics (SLNO) has 1 split in our SLNO split history database. The split for SLNO took place on October 06, 2017. This was a 1 for 5 reverse split, meaning for each 5 shares of SLNO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split.

When a company such as Soleno Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the SLNO split history from start to finish, an original position size of 1000 shares would have turned into 200 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Soleno Therapeutics shares, starting with a $10,000 purchase of SLNO, presented on a split-history-adjusted basis factoring in the complete SLNO split history. SLNO split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 11/14/2014
End date: 05/22/2020
Start price/share: $20.05
End price/share: $4.00
Dividends collected/share: $0.00
Total return: -80.05%
Average Annual Total Return: -25.32%
Starting investment: $10,000.00
Ending investment: $1,995.35
Years: 5.52
Date Ratio
10/06/20171 for 5
SLNO is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

SLS Split History
SLXP Split History
SNOA Split History
SNSS Split History
SRDX Split History
SRPT Split History
SRRA Split History
SSH Split History
SSKN Split History
STAA Split History

Also explore: SLNO shares outstanding history

Laredo Petroleum, Inc. (LPI)
Global Eagle Entertainment Inc. (ENT)
ToughBuilt Industries, Inc. (TBLT)
Cyclacel Pharmaceuticals, Inc. (CYCC)
Chesapeake Energy Corporation (CHK)
Direxion Daily Gold Miners Index Bull 3X Shares (NUGT)
Direxion Zacks MLP High Income Index Shares (ZMLP)
Direxion Daily Retail Bull 3X Shares (RETL)
Direxion Daily Robotics, Artificial Intelligence & Automation Index Bull 3X Shares (UBOT)
Direxion Daily Junior Gold Miners Index Bull 3X Shares (JNUG)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

SLNO Insider Buying

SLNO Split History | www.SplitHistory.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.